
andrea casadei gardini
@casadei_gardini
associated professor; GI cancer specialist; #livercancer #hcc #cca
ID: 1225484989174878208
06-02-2020 18:22:55
229 Tweet
974 Takipçi
1,1K Takip Edilen

🚨 New in ESMO GI Oncology: In aHCC, early Bevacizumab dose mods = worse outcomes. 💡 <45 mg/kg in 3 months ➡️ ☠️ Higher mortality (HR 3.3) 📉 12-mo survival: 53% vs 77% ✅ Full-dose Beva is crucial with AtezBev. Federico Rossari authors.elsevier.com/sd/article/S29…